Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Eyenovia Inc. (EYEN)

  • Technical Exchange News
  • July 27, 2024, 01:36 UTC
  • 43
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Equillium Inc. (EQ)

  • Technical Exchange News
  • July 27, 2024, 01:36 UTC
  • 42
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cytosorbents Crp (CTSO)

  • Technical Exchange News
  • July 27, 2024, 01:36 UTC
  • 46
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Akanda Corp (AKAN)

  • Technical Exchange News
  • July 27, 2024, 01:35 UTC
  • 45
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Seres Therapeutics Inc (MCRB)

  • Technical Exchange News
  • July 26, 2024, 18:51 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Lyra Therapeutics Inc (LYRA)

  • Technical Exchange News
  • July 26, 2024, 18:51 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Im Cannabis Corp (IMCC)

  • Technical Exchange News
  • July 26, 2024, 18:51 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Eyenovia Inc. (EYEN)

  • Technical Exchange News
  • July 26, 2024, 18:51 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Equillium Inc. (EQ)

  • Technical Exchange News
  • July 26, 2024, 18:51 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cytosorbents Crp (CTSO)

  • Technical Exchange News
  • July 26, 2024, 18:51 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 535
  • 536
  • 537
  • 538
  • 539
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191985)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125295)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin